No Data
No Data
Express News | Intellia Therapeutics Names Brian Goff to Its Board of Directors
RBC Capital Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Maintains Target Price $60
RBC Capital analyst Luca Issi maintains $Intellia Therapeutics(NTLA.US)$ with a buy rating, and maintains the target price at $60.According to TipRanks data, the analyst has a success rate of 20.3% an
These 2 Words Are Why Intellia Therapeutics Could Be a Smart Buy Right Now
Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock
On Thursday, Cathie Wood-led Ark Invest made significant trades in Amazon.com Inc (NASDAQ:AMZN) and Reddit Inc (NYSE:RDDT), amidst notable developments in both companies.The Amazon.com Trade: Ark Inve
It Looks Like Intellia Therapeutics, Inc.'s (NASDAQ:NTLA) CEO May Expect Their Salary To Be Put Under The Microscope
Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics
In the last three months, 4 analysts have published ratings on Intellia Therapeutics (NASDAQ:NTLA), offering a diverse range of perspectives from bullish to bearish.The following table summarizes thei
No Data